BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 11 analysts with an average price target of $49.39. This is a potential upside of $24.23 (96.3%) from yesterday's end of day stock price of $25.16.

Beam Therapeutics 's activity chart (see below) currently has 127 price targets and 94 ratings on display. The stock rating distribution of BEAM is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.02% with an average time for these price targets to be met of 88 days.

Highest price target for BEAM is $80, Lowest price target is $21, average price target is $47.44.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 25-Feb-2026. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 12 are a BUY (75%), 4 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Mar-2020

$65

$38.46 (144.91%)

$57

16 days ago
(25-Feb-2026)

3/8 (37.5%)

$35.84 (122.91%)

154

Hold Since 03-May-2021

$26

$-0.54 (-2.03%)

$20

16 days ago
(25-Feb-2026)

9/10 (90%)

$-3.16 (-10.84%)

52

Hold Since 08-Dec-2023

$28

$1.46 (5.50%)

$30

2 months 6 days ago
(07-Jan-2026)

4/4 (100%)

$-0.93 (-3.21%)

133

Buy Since 23-Jul-2024

$80

$53.46 (201.43%)

$80

5 months 3 days ago
(10-Oct-2025)

0/9 (0%)

$53.68 (203.95%)

Buy Since 12-Mar-2025

6 months 22 days ago
(19-Aug-2025)

1/10 (10%)

$12.38 (46.51%)

118

Show more analysts

Please expand the browser size to see the chart

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 88 days on average for the stock forecasts to be realized with a an average price target met ratio 40.02

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Patrick Trucchio with highest potential upside - $53.46

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Gena Wang with lowest potential downside - -$5.54

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?